$NGM NGM BIOPHARMACEUTICALS INC Insider Trading
Get free email notifications about insider trading in NGM BIOPHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NGM BIOPHARMACEUTICALS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in NGM BIOPHARMACEUTICALS INC for free.
CIK Number: 0001426332
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: NGM
Company Address: 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO 94080
Phone number: 650-243-5555
NGM BIOPHARMACEUTICALS INC Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 10 2021 | NGM | NGM BIOPHARMACEUTI ... | LESCHLY MARK | Director | Option Exercise | A | 17.24 | 19,619 | 338,232 | 19,619 | |
Jun 10 2021 | NGM | NGM BIOPHARMACEUTI ... | Ho Carole | Director | Option Exercise | A | 17.24 | 19,619 | 338,232 | 19,619 | |
May 04 2021 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Sell | S | 27.62 | 25,000 | 690,500 | 920,005 | 945 K to 920 K (-2.65 %) |
Apr 13 2021 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Sell | S | 24.65 | 25,000 | 616,250 | 945,005 | 970 K to 945 K (-2.58 %) |
Mar 18 2021 | NGM | NGM BIOPHARMACEUTI ... | Pierce Valerie L | SVP, GC & CCO | Option Exercise | A | 31.93 | 100,000 | 3,193,000 | 100,000 | |
Mar 18 2021 | NGM | NGM BIOPHARMACEUTI ... | Lieu Hsiao D | SVP, Chief Medical ... | Option Exercise | A | 31.93 | 100,000 | 3,193,000 | 100,000 | |
Mar 18 2021 | NGM | NGM BIOPHARMACEUTI ... | Nolan Mangini Siobhan | Chief Financial Off ... | Option Exercise | A | 31.93 | 50,000 | 1,596,500 | 50,000 | |
Mar 18 2021 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Option Exercise | A | 31.93 | 175,000 | 5,587,750 | 175,000 | |
Mar 18 2021 | NGM | NGM BIOPHARMACEUTI ... | WOODHOUSE DAVID J | Chief Executive Off ... | Option Exercise | A | 31.93 | 450,000 | 14,368,500 | 450,000 | |
Mar 18 2021 | NGM | NGM BIOPHARMACEUTI ... | RIEFLIN WILLIAM JL | Executive Chairman | Option Exercise | A | 31.93 | 80,000 | 2,554,400 | 80,000 | |
Mar 02 2021 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Sell | S | 26.66 | 25,000 | 666,500 | 970,005 | 995 K to 970 K (-2.51 %) |
Feb 03 2021 | NGM | NGM BIOPHARMACEUTI ... | Nolan Mangini Siobhan | Chief Financial Off ... | Option Exercise | A | 18.88 | 300,000 | 5,664,000 | 300,000 | |
Feb 03 2021 | NGM | NGM BIOPHARMACEUTI ... | Nolan Mangini Siobhan | Chief Financial Off ... | Option Exercise | A | 18.88 | 300,000 | 5,664,000 | 300,000 | |
Jan 06 2021 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Option Exercise | M | 0.60 | 150,000 | 90,000 | 0 | |
Jan 06 2021 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Buy | M | 0.60 | 150,000 | 90,000 | 1,020,005 | 870 K to 1 M (+17.24 %) |